ERBB2 and breast cancer: Breast cancer is one of the most studied tumors for vaccine therapy.110,111 As previously discussed, HER2 is the most investigated protein for breast cancer patients; however, TNBC patients lack the overexpression of HER2 thus additional antigens need to be investigated with many pre-clinical trials with various antigens and delivery forms.